Previous studies have reported that deletion of Grk5 results in decreased adipocyte differentiation (17) and protection against diet-induced adiposity (15), supporting GRK5 signaling as a therapeutic target for obesity. Here, GRK5 is linked to obesity due to melanocortin 4 receptor deficiency.